Serial 18 F-FDG PET/CT Revealing Mixed Histiocytosis in a Pediatric Patient

Karan Singh1, Loretta Lau, Eva A Wegner

  • 1From the Department of Nuclear Medicine and PET, The Prince of Wales and Sydney Children's Hospitals, Randwick, Australia.

PubMed

Insights

This study presents a rare pediatric case of mixed histiocytosis, where 18F-FDG PET/CT imaging revealed distinct lesions. Serial imaging helped differentiate Langerhans cell histiocytosis from juvenile xanthogranuloma.

Area of Science:

  • Pediatric oncology
  • Nuclear medicine
  • Histopathology

Background:

  • Langerhans cell histiocytosis (LCH) and juvenile xanthogranuloma (JXG) are rare pediatric histiocytic disorders.
  • Distinguishing between LCH and JXG can be challenging, especially in cases with overlapping clinical and imaging features.

Observation:

  • A 6-month-old boy presented with calvarial lytic lesions and soft tissue swelling.
  • 18F-FDG PET/CT revealed hypermetabolic lesions in the skull and femur.
  • Initial biopsy confirmed LCH, but subsequent biopsy of a different lesion showed JXG.

Findings:

  • Serial 18F-FDG PET/CT imaging demonstrated a mixed metabolic response to chemotherapy.
  • Discordant metabolic activity in the femoral lesion indicated a different underlying pathology.
  • Histopathological analysis confirmed a rare co-occurrence of LCH and JXG in a single patient.

Implications:

  • Serial 18F-FDG PET/CT is valuable for monitoring treatment response and detecting discordant disease progression in pediatric histiocytosis.
  • This case highlights the importance of integrating imaging, pathology, and clinical findings for accurate diagnosis and management.
  • Understanding mixed histiocytosis is crucial for optimizing therapeutic strategies in pediatric patients.